Instrument Inactif

Autres langues Dipexium Pharmaceuticals Inc Nasdaq

Actions

US25456J1043

Autres langues

29/09/23	PLx Pharma Winddown Corp. Went Out of Business
14/09/23	First Amended Combined Liquidation Plan and Disclosure Statement Approved for PLx Pharma Winddown Corp.
28/08/23	First Motion for Exclusivity Period Extension Approved For PLx Pharma Winddown Corp.
10/08/23	First Motion for Exclusivity Period Extension Filed by PLx Pharma Winddown Corp.
28/07/23	First Amended Disclosure Statement and Related Plan on Interim Basis Approved for PLx Pharma Winddown Corp.
26/07/23	First Amended Combined Liquidation Plan and Disclosure Statement Filed by PLx Pharma Winddown Corp.
07/07/23	Plx Pharma Winddown Corp. Announces Resignation of Natasha Giordano as Chief Executive Officer
07/07/23	Plx Pharma Winddown Corp. Announces Resignation of Rita Oâ€™Connor as Chief Financial Officer
07/07/23	Plx Pharma Winddown Corp. Announces Executive Changes
07/07/23	Combined Disclousre Statement and Liquidation Plan Filed by PLx Pharma Winddown Corp.
27/05/23	PLx Pharma : Material Agreement - Form 8-K
25/05/23	Motion for Asset Sale Approved for PLx Pharma Winddown Corp.
19/05/23	Notice for Auction Cancellation Filed PLx Pharma Winddown Corp.
10/05/23	Bidding Procedure Approved for PLx Pharma Inc.
17/04/23	PLx Pharma Inc.(OTCPK:PLXP.Q) dropped from S&P TMI Index
17/04/23	PLx Pharma Inc.(OTCPK:PLXP) dropped from S&P TMI Index
14/04/23	Motion for Joint Administration Approved for PLx Pharma Inc.
13/04/23	PLx Pharma : Bankruptcy - Form 8-K
13/04/23	PLX PHARMA INC. : Bankruptcy or Receivership, Financial Statements and Exhibits (form 8-K)
13/04/23	Motion for Asset Sale Filed by PLx Pharma Inc.
13/04/23	Motion for Joint Administration Filed by PLx Pharma Inc.
13/04/23	PLx Pharma Inc. Filed for Bankruptcy
12/04/23	PLx Pharma Signs Stalking Horse Deal to Sell Assets to Greenwood Brands; Shares Jump After Hours
12/04/23	PLX PHARMA INC. : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)
12/04/23	PLx Pharma Inc. Enters into a Stalking Horse Asset Purchase Agreement to Sell VAZALORE® and Substantially All of its Assets